Carl Zeiss Meditec AG (ETR: AFX)

Market Cap	4.96B
Revenue (ttm)	2.07B
Net Income (ttm)	203.20M
Shares Out	89.44M
EPS (ttm)	2.28
PE Ratio	24.36
Forward PE	23.00
Dividend	1.10 (2.01%)
Ex-Dividend Date	n/a

Volume	142,119
Open	55.25
Previous Close	54.65
Day's Range	54.95 - 56.20
52-Week Range	54.45 - 123.75
Beta	0.98
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 11, 2024

About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1846
• Employees: 4,823
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: AFX

Financial Performance

In 2023, Carl Zeiss Meditec AG's revenue was 2.09 billion, an increase of 9.80% compared to the previous year's 1.90 billion. Earnings were 290.40 million, a decrease of -1.20%.